132 related articles for article (PubMed ID: 21296616)
1. Effects of the renin angiotensin system on vasculogenesis-related progenitor cells.
Roks AJ; Rodgers K; Walther T
Curr Opin Pharmacol; 2011 Apr; 11(2):162-74. PubMed ID: 21296616
[TBL] [Abstract][Full Text] [Related]
2. The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function.
Qian C; Schoemaker RG; van Gilst WH; Roks AJ
Clin Sci (Lond); 2009 Feb; 116(4):301-14. PubMed ID: 19138171
[TBL] [Abstract][Full Text] [Related]
3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
4. [Critical role of renin-angiotensin system in the pathogenesis of atherosclerosis].
Hirata Y; Fukuda D; Sata M
Nihon Rinsho; 2011 Jan; 69(1):55-9. PubMed ID: 21226261
[TBL] [Abstract][Full Text] [Related]
5. [The future of renin inhibition].
Uresin AY; Baran E
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
[TBL] [Abstract][Full Text] [Related]
6. [Renin-angiotensin system in atherosclerosis].
Fukuda D; Sata M
Nihon Rinsho; 2006 Apr; 64(4):805-9. PubMed ID: 16613201
[TBL] [Abstract][Full Text] [Related]
7. Does the renin-angiotensin system participate in regulation of human vasculogenesis and angiogenesis?
Khakoo AY; Sidman RL; Pasqualini R; Arap W
Cancer Res; 2008 Nov; 68(22):9112-5. PubMed ID: 19010879
[TBL] [Abstract][Full Text] [Related]
8. Progression of cardiovascular damage: the role of renin-angiotensin system blockade.
Probstfield JL; O'Brien KD
Am J Cardiol; 2010 Jan; 105(1 Suppl):10A-20A. PubMed ID: 20102969
[TBL] [Abstract][Full Text] [Related]
9. The hematopoietic system: a new niche for the renin-angiotensin system.
Hubert C; Savary K; Gasc JM; Corvol P
Nat Clin Pract Cardiovasc Med; 2006 Feb; 3(2):80-5. PubMed ID: 16446776
[TBL] [Abstract][Full Text] [Related]
10. Vascular progenitor cell mobilization.
Kienstra KA; Hirschi KK
Methods Mol Biol; 2012; 904():155-64. PubMed ID: 22890930
[TBL] [Abstract][Full Text] [Related]
11. Tissue renin-angiotensin systems. Their role in cardiovascular disease.
Lee MA; Böhm M; Paul M; Ganten D
Circulation; 1993 May; 87(5 Suppl):IV7-13. PubMed ID: 8485836
[TBL] [Abstract][Full Text] [Related]
12. Are there effects of renin-angiotensin system antagonists beyond blood pressure control?
Bakris G
Am J Cardiol; 2010 Jan; 105(1 Suppl):21A-9A. PubMed ID: 20102970
[TBL] [Abstract][Full Text] [Related]
13. Hepatic fibrosis and the renin-angiotensin system.
Abbas G; Silveira MG; Lindor KD
Am J Ther; 2011 Nov; 18(6):e202-8. PubMed ID: 20535005
[TBL] [Abstract][Full Text] [Related]
14. Diabetes and retinal vascular disorders: role of the renin-angiotensin system.
Wilkinson-Berka JL
Expert Rev Mol Med; 2004 Jul; 6(15):1-18. PubMed ID: 15387897
[TBL] [Abstract][Full Text] [Related]
15. [Renin-angiotensin system as a potential target for the treatment with heart failure: ACE inhibitors, angiotensin-II receptor blockers and aldosterone antagonists].
Sanada S; Kitakaze M
Nihon Rinsho; 2003 May; 61(5):821-6. PubMed ID: 12755009
[TBL] [Abstract][Full Text] [Related]
16. [The current concept of the renin-angiotensin system].
Ibarra-Rubio ME; Pedraza-Chaverrí J
Rev Invest Clin; 1993; 45(2):165-77. PubMed ID: 8337545
[TBL] [Abstract][Full Text] [Related]
17. Endothelial progenitor cells and spleen: new insights in regeneration medicine.
Zhao X; Wu N; Huang L
Cytotherapy; 2010; 12(1):7-16. PubMed ID: 19878079
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
Grothusen A; Divchev D; Luchtefeld M; Schieffer B
Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
[TBL] [Abstract][Full Text] [Related]
19. The role of the renin-angiotensin system in liver fibrosis.
Munshi MK; Uddin MN; Glaser SS
Exp Biol Med (Maywood); 2011 May; 236(5):557-66. PubMed ID: 21508249
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin system modulation for treatment and prevention of cardiovascular diseases: toward an optimal therapeutic strategy.
Giles TD
Rev Cardiovasc Med; 2007; 8 Suppl 2():S14-21. PubMed ID: 17401312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
